A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development.
Schneider AT, Koppe C, Crouchet E, Papargyriou A, Singer MT, Büttner V, Keysberg L, Szydlowska M, Jühling F, Moehlin J, Chen MC, Leone V, Mueller S, Neuß T, Castoldi M, Lesina M, Bergmann F, Hackert T, Steiger K, Knoefel WT, Zaufel A, Kather JN, Esposito I, Gaida MM, Ghallab A, Hengstler JG, Einwächter H, Unger K, Algül H, Gassler N, Schmid RM, Rad R, Baumert TF, Reichert M, Heikenwalder M, Kondylis V, Vucur M, Luedde T.
Schneider AT, et al. Among authors: kondylis v.
Nat Commun. 2025 Feb 19;16(1):1765. doi: 10.1038/s41467-025-56493-7.
Nat Commun. 2025.
PMID: 39971907
Free PMC article.